The Canadian cancer research institute funded by the Terry Fox Foundation, which runs the pan-Canadian Marathon of Hope Cancer Centres Network for precision oncology.
The Terry Fox Research Institute was created by the Terry Fox Foundation to invest the proceeds of the annual Terry Fox Run in translational cancer research across Canada. It funds multi-institutional programme project grants and, through the Marathon of Hope Cancer Centres Network, links Canada's major cancer centres and research institutes in a shared precision medicine effort that harmonises genomic profiling, data sharing and clinical trials so that findings from one province can benefit patients in another. TFRI is a virtual institute headquartered in Vancouver with nodes in every region and works with the Canadian Cancer Society, the Canadian Institutes of Health Research and provincial agencies.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-15.
Matched to Terry Fox Research Institute, including child institutions. 5 works · 9 citations · 40% open access · 0% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade 10.3389/fonc.2022.973402 · open access | Frontiers in Oncology | 2022 | 8 |
| ACTIVATION, EXPANSION, AND CULTURE OF HUMAN T CELLS INCORPORATING IMMUNOCULTTM CGMP-COMPLIANT ANCILLARY REAGENTS 10.1016/j.jcyt.2024.03.389 | Cytotherapy | 2024 | 1 |
| P30-29 A Multi-Lineage in vitro Assessment Platform for Predicting Bone Marrow and Gastrointestinal Toxicity Using PARP Inhibitors as a Model 10.1016/j.toxlet.2026.112776 | Toxicology Letters | 2026 | 0 |
| BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings 10.1139/bcb-2023-0207 · open access | Biochemistry and Cell Biology | 2023 | 0 |
| Faculty Opinions recommendation of Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression. peer review · 10.3410/f.742159970.793594313 | Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | 2022 | 0 |
Shares Jim Woodgett, Terry Fox Foundation.
Shares Ontario Institute for Cancer Research, Princess Margaret Cancer Centre.
Shares Ontario Institute for Cancer Research, Princess Margaret Cancer Centre.
Shares Ontario Institute for Cancer Research, Comprehensive genomic profiling.
Shares Ontario Institute for Cancer Research, Princess Margaret Cancer Centre.
Shares Ontario Institute for Cancer Research, Princess Margaret Cancer Centre.
Shares Ontario Institute for Cancer Research, Princess Margaret Cancer Centre.
Shares Ontario Institute for Cancer Research, Princess Margaret Cancer Centre.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/